Portal hypertension because of liver cirrhosis is a significant cause of morbidity and mortality. Treatment options in these patients include liver transplant, symptomatic treatment of oesophageal varices via endoscopic treatment and symptomatic management of ascites. Portosystemic shunt creation can be challenging in newborns and infants. We present a newborn with Trisomy 21, severe portal hypertension secondary to neonatal cirrhosis, oesophageal varices and upper GI bleeding, severe ascites refractory to medical management who underwent ductus venosus stenting as a palliative procedure. He demonstrated remarkable clinical improvement with no subsequent upper GI bleed and resolution of ascites till his last follow-up at 12 months of age. To the best of our knowledge, stenting of the patent ductus venosus to create a portosystemic shunt to relieve portal hypertension has not been reported in English literature.
|Original language||English (US)|
|Number of pages||5|
|State||Published - Apr 2022|
Bibliographical notePublisher Copyright:
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
- ductus venosus
- neonatal cirrhosis
- portal hypertension
PubMed: MeSH publication types
- Journal Article